KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Net Cash Flow (2016 - 2025)

Exact Sciences (EXAS) has disclosed Net Cash Flow for 16 consecutive years, with $166.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 963.95% to $166.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $348.5 million, a 136554.51% increase, with the full-year FY2025 number at $348.5 million, up 136554.51% from a year prior.
  • Net Cash Flow was $166.9 million for Q4 2025 at Exact Sciences, up from $131.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $309.4 million in Q2 2025 to a low of -$740.1 million in Q2 2021.
  • A 5-year average of -$26.7 million and a median of $19.9 million in 2022 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: crashed 25851.15% in 2021, then soared 963.95% in 2025.
  • Exact Sciences' Net Cash Flow stood at $41.7 million in 2021, then crashed by 90.45% to $4.0 million in 2022, then surged by 222.0% to $12.8 million in 2023, then rose by 22.4% to $15.7 million in 2024, then skyrocketed by 963.95% to $166.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Net Cash Flow are $166.9 million (Q4 2025), $131.9 million (Q3 2025), and $309.4 million (Q2 2025).